In accordance with these findings, our results suggest that individual EP tumours arise secondary to CNAs in multiple known cancer drivers, such as the previously reported genes RB1 and EGFR. Notably, the analyses identified CNAs in distinct, high frequency, and high penetrance cancer genes, which are consistent with the involvement of crucial cancer pathways. This evidence concerns the gene RB1 and neoplasm.